embracing the technology-driven future of pharma and

The summit is created and designed by:

16 NOVEMBER 2021 100% ONLINE

Embracing the Technology-Driven Future of Pharma and Biotech R&D

www.smartlabsummit.com +44 (0) 113 3970 379 [email protected]

“It was truly my pleasure, and an honor, to participate. I feel the

platform worked far better than most I’ve seen used for virtual conferences.”

Cindy Novak-DeLaurell, Senior

Manager, Lab Operations, Systems, Bristol Myers Squibb

No travel costsand time spentaway from the

office

Free access to ALL sessions

and exhibitors

Interactive

Virtual Roundtable Discussion groups

where you can have your questions

answered

On-demand access to all recordings after the event

Flexibility to

select the sessions that are important

to you

0501 02 03 04Just some of the amazing elements of our Virtual event experience:

Sponsors

https://www.amg-world.co.uk/smart-lab-registrations/


https://www.amg-world.co.uk/iot-clinical-trials-registration/

https://www.amg-world.co.uk/iot-clinical-trials-registration/


http://www.smartlabsummit.com


Smart Labs, Automation & Technology US | 16 November 2021 | 100% Online

Your 2021 Agenda:The critical partnership between technology, medicine, scientific discovery and research is constantly evolving. Developing a technology-driven approach, is enabling global pharma and biotech companies to reap the rewards of reduced times to market, enhanced scientific collaboration and optimized R&D.

A combination of strategy, vision, infrastructure, mindset and talent is a prerequisite to drive these types of results, to ensure the successful integration and implementation of digitally optimized, connected smart labs of the future.

Through a series of presentations and interactive discussions, you will acquire the necessary tools to:

Drive lab digitalization at scale through the effective

implementation and integration of lab automation,

robotics and emerging

technology solutions

Develop the infrastructure, framework and culture required for successful migration to

digital processes and tools

Utilize automation to reduce time to market with

accelerated early discovery and technology-led

R&D

Achieve enhanced cross-functional

scientific collaboration with optimized smart lab connectivity

Improve scientific decision-making by harnessing big

data, analytics and advanced

data science for enhanced drug discovery and

research

The European event will address the following areas and explore how to:

Create the strategic roadmap for successful lab digitalization, paving the way for smart, efficient, connected labs of the future

Identify and validate suitable technology solutions to enhance and support your laboratory R&D efforts

Define best-practice automation strategies which will increase lab efficiency, capacity, speed and quality for accelerated early discovery

Develop an effective data quality and analytics strategy that will enhance speed and accuracy of decision-making

Facilitate advanced connectivity and cross-functional collaboration across the enterprise for deeper scientific insights, by leveraging Lab 4.0

Part of the #SLATSummits Series:

www.smartlabeurope.com

7 December 2021

EUROPE

Our European edition will look at the critical transitional phases required for successful lab automation, modernization and digitalization, along with how this journey is evolving specifically within Europe.





Brian Arey Senior Director Leads Discovery and Optimization Bristol Myers Squibb

Moiz Diwan Director, Head of Enabling Technology Group Abbvie

Abhishek Mathur Director, Global Research (Biologics) Amgen

Terryl Kibodeaux Director, R&D Business Relationship Management Regeneron

Jason Ekert Senior Director, Fellow and Head of Complex In Vitro Models In Vitro/In Vivo Translation GSK

Szczepan Baran Head of Emerging Technologies, Comparative Medicine, SO Novartis

Aude Smeets Global Quality Control, Innovation Analytical Technical Expert Automation, Vaccines GSK

Martin Gadsby CEO Optimal Industrial Technologies Ltd.

Martin Trapecar Professor of Medicine John Hopkins University

Arun Veeramani Global Cybersecurity Leader Honeywell Connected Enterprise

Vanessa Jully Senior Manager, Technical R&D Automation Lead GSK

Mary Belfast Senior Scientist, Automation Manager Teva Pharmaceuticals

Tuyen Nguyen Senior Scientist Alnylam Pharmaceuticals

Jonas Anielski Business Manager Digital Solutions Eppendorf AG

Boris Brumshtein Senior Research Scientist Gilead

Your 2021 Speakers Include:

Who Should Attend:

The summit is designed for VPs, Directors, Heads and Managers from: • Automation / Robotics

• R&D

• Lab IT/ Research IT

• Informatics

• Technology & Innovation

• Quality Assurance / Quality Control

• Laboratory Operations & Strategy

• Regulation, Compliance & Validation

• Data & Analytics

• Industry 4.0 / Lab 4.0

• Emerging Technology / Artificial Intelligence (AI) / Machine Learning (ML)

Our sponsors include technology, service & solution providers specializing in: • Laboratory Automation / Lab

Digitalization

• Robotics

• Informatics

• Data & Analytics

• Artificial Intelligence (AI) / Machine Learning (ML)

• Cloud Computing

• IoT Hardware, Software, Platforms, Infrastructure

• Cyber Security





07:55 – 08:00 Opening Remarks from AMG World

08:00 – 09:00 Unlocking the True Potential of IoLT (Internet of Laboratory Things): This panel discussion will examine the benefits, challenges and best-practice strategies for achieving successful and sustainable lab digitalization. The expert panelists will explore how they are balancing technology integration, implementation and the migration towards digital tools. • How can we balance the resources required to achieve lab automation and digitalization at scale? • How to develop best-practice data handling and utilization strategies which can be rolled out to optimize cross-functional enterprise collaboration • Integration and implementation: Facilitating the effective introduction of automation, robotics and emerging technology solutions within the lab environment • Infrastructure and framework: Managing the migration from manual to digital tools when striving for end-to-end lab automation • Outside the box thinking: How to identify and evaluate traditional processes which can benefit from automation and novel areas ripe for digital transformation

Panelists:Brian Arey, Senior Director Leads Discovery and Optimization, Bristol Myers SquibbTerryl Kibodeaux, Director, R&D Business Relationship Management, RegeneronAbhishek Mathur, Director, Global Research (Biologics), AmgenMary Belfast, Senior Scientist, Automation Manager, Teva PharmaceuticalsTuyen Nguyen, Senior Scientist, Alnylam PharmaceuticalsBoris Brumshtein, Senior Research Scientist, Gilead

09:05 – 09:35 Achieving Lab Automation: The Complete 360° Lifecycle of Successful Lab Automation In this keynote presentation, Aude and Vanessa will explore GSK’s strategy, evaluation, integration and implementational phases of automating their QC focused analytical labs and technical R&D Labs. They will explain what considerations must be taken, and how to facilitate innovation and technology transition when migrating from manual to automated processes.

• Where to start with lab automation• Managing the effective assessment and evaluation of enabling technology for analytical and technical R&D labs• Balancing technology with compliance: How to remain compliant with regulatory requirements when integrating technology in regulated technical R&D and QC focused labs• Facilitating a harmonious transition: How to create an inclusive digital journey for stakeholders migrating from manual to digital methods

Presenters:Aude Smeets, Global Quality Control, Innovation Analytical Technical Expert Automation, Vaccines, GSK Vanessa Jully, Senior Manager, Technical R&D Automation Lead, GSK

09:40 – 10:00 Technology DemonstrationsMeet with our sponsors at the virtual booth to watch their 10-minute technology demonstration. This is your opportunity to meet with the team face-to-face, see their solution in action and have your direct questions answered.

10:00 – 10:30 Networking Break and Virtual Exhibition

Agenda: 16 November 2021

VIRTUAL ROUNDTABLE

KEYNOTE PRESENTATION

All timings are Pacific Standard Time

“I thought the mix of people in my session was great.” Jason Ekert, Senior Director, Fellow and Head of Complex In Vitro Models In Vitro/In Vivo Translation, GSK





10:30 – 11:00 How to Overcome the Reproducibility Crisis with Digitalization? • Leverage digital technology for experiment productivity and reproducibility from design to

optimization. • How can the effort for experiment documentation be reduced while increasing the quality of

documentation to drive reproducibility in and across labs? • IoT technology and web-based services are key to delivering the next steps towards a

flexible digital experiment experience that goes beyond copying an existing analogue process into a digital one.

• What are the challenges of moving towards a digital experiment - in particular in R&D labs? • Why a structured data approach helps to boost traceability and enables the optimization of

scientific processes Jonas Anielski, Business Manager Digital Solutions, Eppendorf AG

11:05 – 11:35 Leveraging PAT Knowledge Management Technology in Your Laboratories • The importance of streamlining and speeding up the process transition from R&D to

production • Automating repetitive analysis tasks and integrating with robotics to optimize processes • Creating simple or complex workflows containing one or multiple instruments • Data & analytics: Collecting data within a regulatory compliant framework, adding meta data

to the measurements, and leveraging analytics to make real-time quality predictions Martin Gadsby, CEO, Optimal Industrial Technologies Ltd.

11:40 – 12:15 Networking Lunch and Virtual Exhibition

12:15 – 13:15 Embracing the Technologically Optimized Future of Pharma Experimentation, Discovery and R&D This panel will explore the true potential of what can be achieved with technology innovations in modern, digitally optimized labs of the future. The panelists will also explore how to unlock opportunities by harnessing a technology-driven approach to scientific discovery, research and development. • Extended reality and digital twins: Examining the advanced digitalization of laboratory

processes • Unlocking opportunities with labs of the future: How to effectively integrate next-generation

technologies, organoids, body-on-a-chip (BOC), bioprinting and microphysiological systems (MPS) into existing pharma workflows

• Vision vs reality the future of lab digitalization: What are the realistic possibilities that can be achieved with end-to-end lab automation?

• Culture, talent and mindset: How to convey the message to demystify the journey towards digital transformation of pharma R&D labs

• How to evaluate, validate and verify the suitability, and flexibility of advanced lab technology? Achieving strategic alignment between business objectives and technology innovations

Panellists:Moiz Diwan, Director, Head of Enabling Technology Group, AbbvieJason Ekert, Senior Director, Fellow and Head of Complex In Vitro Models In Vitro/In Vivo Translation, GSKSzczepan Baran, Head of Emerging Technologies, Comparative Medicine, SO, Novartis Martin Trapecar, Professor of Medicine, John Hopkins University

13:20 – 13:50 Reducing OT Cybersecurity Risk with Early Threat Detection & Incident Response Arun Veeramani, Global Cybersecurity Leader, Honeywell Connected Enterprise

13:50 Close of the conference

Agenda: 16 November 2021 All timings are Pacific Standard Time

VIRTUAL ROUNDTABLE





How can you get involved as a sponsor?

You will be positioned as industry experts amongst the most prominent and influential players within pharmaceutical and biotechnology R&D. The Smart Labs, Automation and Technology US Virtual Event will offer maximum coverage and exposure to a highly engaged and motivated audience, providing a hugely exciting opportunity and platform for you to effectively position your brand whilst highlighting your capabilities to a wider global audience.

What will you receive as part of sponsorship package?

J A one hour closed door roundtable facilitation role with fully qualified delegates where you will moderate the discussion with qualified panellists

J 30-minute virtual presentation with both audio and visual content which is broadcast to a live audience within your target demographic, promoting thought leadership and generating quality leads.

J The opportunity to establish contact with qualified budget holders prior to the event to optimize the discussion and ensure you topic is aligned and your time optimized

J Virtual pre-arranged one-to-one meetings with qualified delegates that are actively that are actively looking for solutions to solve their problems.

J Thought leadership and brand awareness

We would welcome the opportunity to discuss various options in more detail, for more information please contact:

Your 2021 sponsors:

Simon Wright, CEO, AMG World

E: [email protected]

T: +1 678 534 8541 / +44 7734 666 249



embracing the technology-driven future of pharma and

Documents